Quarterly report pursuant to Section 13 or 15(d)

Supplemental Equity and Accumulated Other Comprehensive Income (Loss) - Consolidated Changes in Equity (Details)

Supplemental Equity and Accumulated Other Comprehensive Income (Loss) - Consolidated Changes in Equity (Details) - USD ($) $ in Thousands	3 Months Ended
	Sep. 30, 2023	Sep. 30, 2022
Balances	$ 1,966,516	$ 1,701,011
Balances (in shares)	157,641,914
Net earnings	$ 50,993	89,734
Other comprehensive loss	(11,952)	(16,762)
Reclassification of cumulative translation adjustment for Eminence to non-operating income		119
Elimination of noncontrolling equity interest from sale of Eminence		613
Share repurchases		(19,562)
Common stock issued for exercise of options	$ (2,577)	$ (2,005)
Common stock issued for exercise of options (in shares)	1,027,777	660,120
Common stock issued for restricted stock awards	$ (4,767)	$ (6,427)
Cash dividends	(12,654)	(12,545)
Stock-based compensation expense	9,981	14,364
Common stock issued to employee stock purchase plan	2,094	2,517
Employee stock purchase plan expense	112	97
Balances	$ 1,997,746	1,751,154
Balances (in shares)	158,354,579
Common Stock
Balances	$ 1,576	$ 1,566
Balances (in shares)	157,642,000	156,644,000
Share repurchases		$ (2)
Share repurchases (in shares)		(222,000)
Common stock issued for exercise of options	$ 6	$ 5
Common stock issued for exercise of options (in shares)	633,000	425,000
Common stock issued for restricted stock awards	$ 1	$ 0
Common stock issued for restricted stock awards (in shares)	47,000	45,000
Common stock issued to employee stock purchase plan	$ 1	$ 0
Common stock issued to employee stock purchase plan (in shares)	33,000	36,000
Balances	$ 1,584	$ 1,569
Balances (in shares)	158,355,000	156,928,000
Additional Paid-in Capital
Balances	$ 721,543	$ 652,467
Common stock issued for exercise of options	12,877	9,418
Common stock issued for restricted stock awards	0	0
Stock-based compensation expense	9,981	14,364
Common stock issued to employee stock purchase plan	2,093	2,517
Employee stock purchase plan expense	112	97
Balances	746,606	678,863
Retained Earnings
Balances	1,309,461	1,122,937
Net earnings	50,993	89,555
Share repurchases		(19,560)
Common stock issued for exercise of options	(15,460)	(11,428)
Common stock issued for restricted stock awards	(4,768)	(6,427)
Cash dividends	(12,654)	(12,545)
Balances	1,327,572	1,162,532
Accumulated Other Comprehensive Income
Balances	(66,064)	(75,200)
Other comprehensive loss	(11,952)	(16,762)
Reclassification of cumulative translation adjustment for Eminence to non-operating income		152
Balances	$ (78,016)	(91,810)
Noncontrolling Interest
Balances		(759)
Net earnings		179
Reclassification of cumulative translation adjustment for Eminence to non-operating income		(33)
Elimination of noncontrolling equity interest from sale of Eminence		$ 613